Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
May
13
2014
Cotropia Study of USPTO Allowance Rate is Total Bunk – Methodology Can Easily Result in “Normalized Allowance Rates” far in Excess of 100% the Lower the Actual Allowance Rate Goes Schwegman, Lundberg & Woessner, P.A.
Jul
18
2016
Patent Due Diligence and Evaluation After America Invents Act Schwegman, Lundberg & Woessner, P.A.
Apr
3
2020
Top 10 Considerations for Medtech Inventors Schwegman, Lundberg & Woessner, P.A.
Sep
14
2016
Federal Circuit Emphasizes Preemption and Realization as the Path to Eligibility Schwegman, Lundberg & Woessner, P.A.
Sep
20
2016
UCB v. Yeda R&D Co. – No “Safe Harbor” for Unamended Claims Schwegman, Lundberg & Woessner, P.A.
May
14
2020
China Launches “Iron Fist” Intellectual Property Law Enforcement Plan for 2020 Schwegman, Lundberg & Woessner, P.A.
Jun
22
2020
Biogen v. Mylan: When Does a Specification Fail to Describe a Newly-Presented Claim? Schwegman, Lundberg & Woessner, P.A.
Nov
1
2016
More Good News for Software Patents: Amdocs (Israel) Limited v. Opnet Telecom, Inc., 2015-1180, Fed. Cir. Schwegman, Lundberg & Woessner, P.A.
Aug
4
2014
Ignorance is Bliss – for Teva re: Structural Obviousness in Patent Cases Schwegman, Lundberg & Woessner, P.A.
Aug
6
2020
Shanghai Police Announce Arrests in Hasbro Transformers Criminal Copyright Case Schwegman, Lundberg & Woessner, P.A.
Sep
15
2020
China’s First COVID-19 Virus Vaccine Patent Granted to CanSino Bio Schwegman, Lundberg & Woessner, P.A.
Dec
7
2020
Prison for over 200 fraudulent Chinese patent applications yielding 900,000 RMB in government awards Schwegman, Lundberg & Woessner, P.A.
Apr
3
2017
ChanBond Avoids Institution of Six Cisco IPR Petitions Schwegman, Lundberg & Woessner, P.A.
Oct
24
2014
AIPLA Announces New Executive Director Schwegman, Lundberg & Woessner, P.A.
Feb
17
2021
Colgate-Palmolive Not Rebranding China’s Darlie/Black Person’s Toothpaste Based on Recent Trademark Filings? Schwegman, Lundberg & Woessner, P.A.
Nov
13
2014
C.I.T. v. Hughes Comm. – Survival Guide for Software? Schwegman, Lundberg & Woessner, P.A.
Mar
14
2021
China Releases Draft Measures for Administrative Adjudication of Major Patent Infringement Disputes for Comment Schwegman, Lundberg & Woessner, P.A.
May
20
2021
China’s Center for Drug Evaluation Opens Patent Linkage Registration Platform for Public Testing Schwegman, Lundberg & Woessner, P.A.
Jul
31
2017
Inequitable Conduct Intent Prong Due to Litigation Misconduct Schwegman, Lundberg & Woessner, P.A.
Jul
20
2021
China’s General Administration of Customs Announces Typical Cases of Intellectual Property Infringement Schwegman, Lundberg & Woessner, P.A.
Jul
27
2021
Criminal Arrests for Intellectual Property Crimes in China Up 99% in H1 2021 Schwegman, Lundberg & Woessner, P.A.
Feb
16
2015
Unified Patents’ Institution Decision Gives Insight to PTAB’s Real Party in Interest Analysis Schwegman, Lundberg & Woessner, P.A.
Sep
17
2021
China’s National People’s Congress Releases Translation of the Amended Patent Law Schwegman, Lundberg & Woessner, P.A.
Sep
22
2021
The Central Committee of the Communist Party of China and the State Council issued the “Guidelines for Building a Powerful Country with Intellectual Property Rights (2021-2035)” Schwegman, Lundberg & Woessner, P.A.
Apr
1
2011
Banning Stem Cell Research — Or Cloning? Or Both? Schwegman, Lundberg & Woessner, P.A.
Apr
13
2011
Myriad Oral Arguments – Section 101 vs. Chemistry 101? Schwegman, Lundberg & Woessner, P.A.
May
30
2011
Therasense Makes Sense of Inequitable Conduct Defense Schwegman, Lundberg & Woessner, P.A.
Jun
7
2011
Reexamination Practice: One Size Does Not Fit All Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins